# Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes

> **NCT06535789** · PHASE2,PHASE3 · RECRUITING · sponsor: **Jaeb Center for Health Research** · enrollment: 30 (estimated)

## Conditions studied

- Diabetes, Gestational
- Pregnancy Complications
- Glucose Metabolism Disorders
- Glucose Intolerance During Pregnancy

## Interventions

- **DRUG:** Inhaled Technosphere Insulin

## Key facts

- **NCT ID:** NCT06535789
- **Lead sponsor:** Jaeb Center for Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05
- **Primary completion:** 2025-07
- **Final completion:** 2025-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06535789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06535789, "Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06535789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*